[11] A community-wide survey might have provided weighting and evaluation criteria shared by the cancer vaccine community ... clinical trials using a specific antigen; evidence of immune responses ...
Like other prostate-specific antigen assays, it analyzes a blood sample to look for heightened levels of PSA, which may indicate the presence of prostate cancer; unlike many competing tests ...
Issuer: CureVac / Key word (s): Conference/Study results CureVac’s CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress ...